Overall, the findings revealed that DR5/TRAIL-mediated apoptosis pathway had played important roles in the injury of ARS mice, and DR5 probably be a potential target for ARS therapeutics. Here, TNFSF10 is linked to Axenfeld-Rieger syndrome.